US 11447488
Heterocyclic compounds
granted A61KA61K31/4184A61K31/437
Quick answer
US patent 11447488 (Heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4184, A61K31/437, A61K31/5377, A61K31/553